Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Immune Profiling Evaluation of Newly Diagnose Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients Treated with Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone. Preliminary Results

Allan de souza Santos, BS, Herbert Henrique de Melo Santos, MD, Marco Aurelio Salvino, MD PhD, Sarah Queiroz Silva, MD, Larissa Ferreira Lucas, MD, Alessandro de M. Almeida, MD, Mariane Melo Santos, BS, MsC, Juliana Andrade Santos, MD, Vania T. M. Hungria, MD PhD, Maria da Gloria B. Arruda, MD PhD, Alex Torres, PhD, Edvan De Queiroz Crusoe, MDPhD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-141438

Published: 2020

Journal Articles

Preliminary Results of Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Newly Diagnosed Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients

Edvan De Queiroz Crusoe, MDPhD, Marco Aurelio Salvino, MD PhD, Sarah Queiroz Silva, MD, Herbert Henrique de Melo Santos, MD, Allan de souza Santos, BS, Alessandro de M. Almeida, MD, Lucas de Oliveira Vieira, MD, Cleverson Alves Fonseca, Pham, Larissa Ferreira Lucas, MD, Joanna Leal, MD, Mariane Melo Santos, BS, MsC, Juliana Andrade Santos, MD, Elisangela Adorno, Pham, PhD, Vania T. M. Hungria, MD PhD, Maria da Gloria B. Arruda, MD PhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-138873

Published: 2020